Details for New Drug Application (NDA): 216969
✉ Email this page to a colleague
The generic ingredient in CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE is chlordiazepoxide hydrochloride; clidinium bromide. There are nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride; clidinium bromide profile page.
Summary for 216969
Tradename: | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE |
Applicant: | Alembic |
Ingredient: | chlordiazepoxide hydrochloride; clidinium bromide |
Patents: | 0 |
Pharmacology for NDA: 216969
Mechanism of Action | Cholinergic Antagonists |
Physiological Effect | Decreased Parasympathetic Acetylcholine Activity Digestive/GI System Activity Alteration GI Motility Alteration |
Suppliers and Packaging for NDA: 216969
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | chlordiazepoxide hydrochloride; clidinium bromide | CAPSULE;ORAL | 216969 | ANDA | Alembic Pharmaceuticals Limited | 46708-744 | 46708-744-31 | 100 CAPSULE in 1 BOTTLE (46708-744-31) |
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | chlordiazepoxide hydrochloride; clidinium bromide | CAPSULE;ORAL | 216969 | ANDA | Alembic Pharmaceuticals Limited | 46708-744 | 46708-744-91 | 1000 CAPSULE in 1 BOTTLE (46708-744-91) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 5MG;2.5MG | ||||
Approval Date: | Sep 15, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription